
Patents In The Psychedelics Space: Good Or Bad? It's Complicated, Here's What The Experts Say

Massachusetts Marijuana Sales Surpass $3 Billion, According To Cannabis Control Commission

Gavin Newsom's Cannabis Tax-Cut Proposal: Industry Leaders Complain It Doesn't Fix Key Problems

Awakn's Study On Psychedelics For Treating Addiction Shows Promise, Will Undertake Broader Research

MindMed Reports Promising Results For Non-Hallucinogenic Ibogaine Congener Substance

Novamind To Offer Ketamine Treatment To Frontline Workers Who Suffer Pandemic-Related Distress

CSIRO, Australia's National Science Agency, Gets In The Psychedelics Space

EXCLUSIVE: Bexson Biomedical's CSO Says Subcutaneous Ketamine Could Treat Wide Range Of Health Issues

Licensed Cultivator Selling Marijuana On Facebook Caught By Police, 22,000 Plants Destroyed

Optimi Health Adds Large Portfolio Of Magic Mushrooms Strains To Its Genetic Bank

Psychedelics Retreats Coming To Canada Could Soon Offer Psilocybin Treatment

Numinus Granted Canada's Special Access Program For Magic Mushrooms To Treat Life-Threatening Conditions

Irwin Naturals Continues To Expand In Psychedelics Space, Acquires New Ketamine Clinic

Red Light Holland Sends Magic Mushrooms Into Canada To Be Used As Pharmaceutical Ingredients

MindMed Reports Financial Results For Q1, With Lower Cash Balance Compared To December Last Year

Beckley Retreats Launches To Offer Magic Mushroom Retreats In Jamaica

Has Clearmind Developed A Psychedelics-Based Drug That Can Treat Alcoholism? The FDA Is Interested

Irwin Naturals And Assurance Laboratories Reach Licensing Agreement For THC Products In New Mexico

Veterans In Arizona Will Have Access To Ketamine Therapy At No Out-Of-Pocket Cost

Colorado Activists Push To Add Psychedelics Reform Onto November Ballot